These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3569760)

  • 61. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
    Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
    Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.
    Planas R; Arroyo V; Rimola A; Pérez-Ayuso RM; Rodés J
    Gastroenterology; 1983 Feb; 84(2):247-52. PubMed ID: 6401254
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Renal function and renin secretion after administration of ouabain and ouabain plus furosemide in conscious sheep.
    Blaine EH; Zimmerman MB
    Circ Res; 1978 Jul; 43(1):36-43. PubMed ID: 657458
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Christos P; Paraskevi K; Konstantinos P; Katsaraki A; Tsianos EV
    Dig Dis Sci; 2005 Oct; 50(10):1771-7. PubMed ID: 16187171
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Furosemide kinetics in patients with hepatic cirrhosis with ascites.
    Fuller R; Hoppel C; Ingalls ST
    Clin Pharmacol Ther; 1981 Oct; 30(4):461-7. PubMed ID: 7285480
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of experimental azotemia on renal clearance of furosemide in the dog.
    Rose HJ; Pruitt AW; McNay JL
    J Pharmacol Exp Ther; 1976 Jan; 196(1):238-47. PubMed ID: 1246013
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Renal haemodynamic actions of pressor doses of lysine vasopressin in the rat.
    Lote CJ; McVicar AJ; Thewles A
    J Physiol; 1987 Oct; 391():407-18. PubMed ID: 3443952
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 'Diuretic-resistant' ascites. Observations on pathogenesis.
    Rector WG
    Arch Intern Med; 1986 Aug; 146(8):1597-600. PubMed ID: 3729643
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of furosemide on renal function of the newborn piglet.
    Noordewier B; Bailie MD; Hook JB
    Pediatr Pharmacol (New York); 1980; 1(2):113-20. PubMed ID: 7346735
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Competition of organic anions for furosemide and p-aminohippurate secretion in the rabbit.
    Bidiville J; Roch-Ramel F
    J Pharmacol Exp Ther; 1986 May; 237(2):636-43. PubMed ID: 3701646
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Atrial natriuretic peptide improves pulmonary gas exchange by reducing extravascular lung water in canine model with oleic acid-induced pulmonary edema.
    Mitaka C; Hirata Y; Habuka K; Narumi Y; Yokoyama K; Makita K; Imai T
    Crit Care Med; 2002 Jul; 30(7):1570-5. PubMed ID: 12130981
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
    Simón MA; Díez J; Prieto J
    Gastroenterology; 1991 Nov; 101(5):1354-60. PubMed ID: 1936807
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.
    Pichette V; Geadah D; du Souich P
    Drug Metab Dispos; 1999 Jan; 27(1):81-5. PubMed ID: 9884313
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
    Swärd K; Valsson F; Sellgren J; Ricksten SE
    Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects.
    Golper TA; Noonan HM; Elzinga L; Gilbert D; Brummett R; Anderson JL; Bennett WM
    Clin Pharmacol Ther; 1988 May; 43(5):565-70. PubMed ID: 3365918
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Renal clearance of urea, inulin, and p-aminohippurate in heat-acclimated rats.
    Chayoth R; Kleinman D; Kaplanski J; Sod Moriah UA
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Sep; 57(3):731-2. PubMed ID: 6490459
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Renal clearance and isolated kidney perfusion techniques.
    Maack T
    Kidney Int; 1986 Aug; 30(2):142-51. PubMed ID: 3020304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.